ClimateCamp
Seed Round in 2025
ClimateCamp is a developer of a greenhouse gas accounting platform aimed at de-carbonizing supply chains. The platform provides detailed information on carbon emissions throughout the supply chain, enabling companies to gain a comprehensive view of their carbon footprint. By facilitating collaboration among key stakeholders, ClimateCamp offers up-to-date insights into emissions, allowing businesses to efficiently target their reduction efforts.
Elis is a multi-services group operating in Europe and Brazil, specializing in the rental and maintenance of professional clothing, flat linen, and hygiene appliances. The company provides a wide range of tailored solutions, including services for washrooms, floor protection, beverages, cleanrooms, pest control, and medical waste management. With over 19,000 employees across 13 countries, Elis serves more than 240,000 businesses in various sectors, including hospitality, healthcare, industry, retail, and services. The company's extensive network of nearly 300 production and distribution centers, alongside 13 clean rooms, enables it to maintain strong proximity to its clients and deliver high-quality services efficiently. With over a century of experience, Elis has established itself as a leader in cleanliness, image, hygiene, and well-being services.
MICLEDI Microdisplays
Series A in 2024
MICLEDI Microdisplays BV is a Belgium-based company that specializes in the design and manufacture of micro light emitting diode (LED) display chips for augmented reality (AR) glasses. As a fabless developer, MICLEDI focuses on innovative technologies that combine III/V materials processing with 3D integration and 300mm silicon-based processing. The company aims to deliver high-quality, power-efficient AR displays by utilizing a proprietary ASIC, which allows for the creation of compact and self-contained display modules. Serving the semiconductor industry, MICLEDI is positioned at the forefront of microLED technology, contributing to the advancement of augmented reality applications.
Discai is a subsidiary of KBC Group that specializes in providing innovative AI solutions tailored for the financial services sector. By commercializing KBC's in-house developed AI applications, Discai aims to set new standards in the industry. The company offers a digital platform that features proven AI-based alternatives, allowing financial service providers to streamline their operations and concentrate on their core business functions. Through a Bank/Insurance-as-a-Service model, Discai gradually releases its applications to make advanced technology accessible to various players in the financial world, thereby enhancing reliability and helping businesses navigate technological and regulatory changes effectively.
Settle is a technology-driven company focused on enhancing the experience of home renovation and property transactions. It provides a digital platform that aids users in optimizing their budgets for house renovations by offering insights into price estimates, renovation costs, and local vacancies. Settle aims to increase transparency in the renovation process, helping clients make informed decisions that align with their financial goals. Additionally, the company facilitates seamless collaboration by connecting digital files to payment, reducing friction in exchanges and fostering trust within the professional community. By addressing the challenges of outdated tools and processes, Settle strives to empower users to work more efficiently and effectively in a digital-first environment.
Unbox, founded in 2020 and headquartered in Antwerp, Belgium, specializes in creating closed-loop systems that facilitate the efficient and transparent distribution of funds. The company's innovative approach ensures that financial resources are directed precisely to their intended recipients, thereby enabling governments, brands, and non-profits to optimize their working capital. By eliminating issues such as leakage and slippage, Unbox enhances accountability and effectiveness in fund distribution, making it a valuable partner for organizations seeking to improve financial management and resource allocation.
Raiffeisenbank
Acquisition in 2021
Raiffeisenbank Bulgaria is a financial institution offering a wide range of banking products and services to both individual and corporate clients. Its offerings include retail and corporate banking, investment services, mortgage lending, credit and debit card facilities, savings accounts, loans, and insurance. The bank caters to individuals as well as micro, small, medium, and large enterprises, institutional clients, and treasuries.
Guud Woman
Pre Seed Round in 2021
Guud Woman is a platform dedicated to improving menstrual health for women by providing a range of natural supplements and support. The company offers products aimed at hormonal balance, fertility, and overall well-being, including serums and capsules for skin and hair health. By vertically integrating these resources, Guud Woman aims to empower women to take charge of their health and well-being through accessible and effective solutions tailored to their specific needs.
NN Group-Pension and life insurance business
Acquisition in 2021
NN Group-Pension and life insurance businesses offer Life Insurance, Mandatory Pensions, and Voluntary Pensions.
Stellar Labs
Seed Round in 2020
Stellar Labs is a company focused on transforming professional learning through innovative, science-based approaches. Their platform utilizes AI-driven design and neuroscience-based GEAR methodology to create efficient, engaging, and effective learning experiences. Key features include rapid design and delivery of training materials, evidence-based learning for maximum knowledge retention, adaptive learning paths tailored to individual needs, and measurable results that demonstrate performance improvements. Stellar Labs aims to empower workforces by accelerating skill acquisition and fostering a culture of continuous learning, ultimately enhancing productivity and adaptability in the workplace.
Wizata SA is a company based in Capellen, Luxembourg, that specializes in developing platform-as-a-service solutions tailored for the manufacturing industry. Founded in 2014, Wizata's software focuses on enhancing quality control, maintenance, and overall performance within manufacturing processes. The company leverages artificial intelligence to provide tools that optimize production processes, ensure quality sustainability, and facilitate predictive maintenance. Wizata addresses specific sector challenges across various domains, including manufacturing, insurance, energy, healthcare, and e-commerce. By integrating its solutions into clients' operations, Wizata's data scientists work collaboratively with teams to uncover insights and opportunities within both internal and external data, thereby enabling organizations to effectively navigate the complexities of modern manufacturing.
ArtiQ is an innovative spin-off company from the University of Leuven, established in early 2019 by founders with extensive backgrounds in respiratory medicine, medical devices, and artificial intelligence. The company focuses on enhancing the diagnosis, treatment, and management of respiratory diseases through advanced technology. ArtiQ has developed AI-based software that automates the interpretation of pulmonary function tests, enabling medical professionals to accurately and efficiently detect disease patterns and assess lung function. This technology not only aids in the early identification of lung diseases but also provides healthcare practitioners with recommendations on subsequent patient care actions. ArtiQ aims to serve as a trusted partner for medical practitioners in the respiratory field, positively impacting patients, doctors, and the healthcare system.
Joyn Belgium
Seed Round in 2017
Joyn Belgium operates a customer engagement platform that enhances the relationship between merchants and their customers. The platform allows users to utilize a loyalty card that enables them to earn rewards points while shopping at their preferred stores. Customers can redeem these points for various benefits, including discounts and prizes, fostering loyalty and repeat business. By integrating the efforts of numerous local merchants, Joyn provides a unified app that offers unique advantages to customers, encouraging them to return to participating businesses. This approach not only supports merchants in growing their customer base but also helps consumers discover valuable rewards and promotions from a diverse range of local retailers.
United Bulgarian Bank
Acquisition in 2016
United Bulgarian Bank is a financial institution based in Sofia, Bulgaria, offering a wide range of banking products and services to individual, microbusiness, and corporate clients. The bank provides various deposit options, including savings accounts, current accounts, and online deposits. In addition to its deposit services, United Bulgarian Bank offers an extensive array of loan products such as consumer loans, mortgage loans, and working capital loans, as well as specialized loans under European and guarantee programs. The bank also facilitates access to debit and credit cards and provides services in insurance, investment banking, mobile banking, and trade finance. Through its comprehensive offerings, the bank aims to deliver personalized banking solutions to meet the diverse needs of its clients.
Interlease
Acquisition in 2016
Interlease is a Bulgarian lease company owned by KBC Group, a Belgian banking and insurance entity. The company specializes in enhancing the competitiveness and market positions of Bulgarian enterprises both domestically and internationally. Interlease finances the acquisition of high-quality equipment, transportation vehicles, cars, and office equipment. It offers professional after-sales service utilizing effective internet and mobile technologies, ensuring clients can select their suppliers and asset types to best suit their business needs.
Go Vocal
Seed Round in 2016
Go Vocal is a digital community engagement platform designed to facilitate interactions between local governments and their communities. The platform serves as a centralized tool for conducting surveys, ideation, participatory budgeting, deliberation, and information sharing. By harnessing artificial intelligence and natural language processing, Go Vocal enables the automatic moderation and analysis of citizen input, transforming unstructured feedback into actionable insights. This functionality allows governments to engage more effectively with citizens, manage their ideas efficiently, and make informed decisions based on real-time data. Through its innovative approach, Go Vocal aims to enhance inclusivity and responsiveness in governmental decision-making processes.
VB LEASING SK, spol. s r.o.
Acquisition in 2015
VB LEASING SK, spol. s r.o. is a leasing company based in Bratislava, Slovakia, established in 1994. The company specializes in financing movable objects, including personal and utility vehicles, machinery, equipment, and computing technology solutions. It also provides financing through credit options, catering to both corporate and private clients. With a network of 11 branches and 90 dealers and agents, VB LEASING SK employs around 90 full-time staff. Originally known as LB-Leasing spol. s r.o., the company rebranded in 2002 and now operates as a subsidiary of CSOB Leasing, a.s.
Pronota NV is a Belgian company focused on developing and commercializing innovative diagnostics aimed at the early detection of life-threatening conditions and addressing unmet medical needs. Established in 2004 and based in Zwijnaarde, the company specializes in non-invasive, validated protein biomarker diagnostics. Its portfolio includes tests for conditions such as heart failure, pre-eclampsia, and sepsis, among others. Pronota is dedicated to enhancing patient care through its proprietary diagnostic solutions. The company benefits from a strong network of investors and key opinion leaders in the medical field, reflecting its commitment to advancing diagnosis and personalized healthcare. Pronota was previously known as Peakadilly NV until its name change in November 2006.
Baltic Investment Company
Acquisition in 2011
BIC specialises in assisting international investors in acquiring businesses, as well as local companies in attracting strategic partners, and can look back on a number of successfully completed M&A transactions. From one region to another, the value of the deals it works on varies between 10 and 200 million euros. Its business portfolio is spread evenly across the various regions in which the company operates. BIC targets midcaps and is a strong player in the financial services, consumer goods, retail, distribution and selected industrial sectors.
Biocartis
Series B in 2010
Biocartis SA, established in 2007 and headquartered in Lausanne, Switzerland, is a molecular diagnostics company specializing in developing diagnostic technology platforms for multiplexed detection of bio-analytes such as proteins, nucleic acids, and small molecules. The company focuses on integrated molecular and immunodiagnostics using its proprietary micro-technology platform, offering products like the Idylla system for oncology and infectious disease segments. These products aid in early detection, staging, treatment selection, and monitoring of diseases by analyzing bio-molecules associated with risk factors. Biocartis generates revenue primarily through product sales.
Argenx is a global immunology company based in the Netherlands, dedicated to enhancing the lives of individuals affected by severe autoimmune diseases and cancer. The company specializes in antibody engineering technology to develop treatments for rare autoimmune conditions. Its lead product, Vyvgart (efgartigimod), received initial approval in the United States in December 2021 for the treatment of generalized myasthenia gravis, followed by subsequent approvals in Europe and Japan in 2022. Through its innovative approaches, Argenx aims to address significant unmet medical needs in the field of immunology.
CymaBay Therapeutics
Series E in 2009
CymaBay Therapeutics, Inc., established in 1988 and headquartered in Newark, California, is a clinical-stage biopharmaceutical company dedicated to developing therapies for liver diseases and other chronic conditions with significant unmet medical needs. Its primary focus is on seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta, currently in Phase II trials for treating primary biliary cholangitis, sclerosing cholangitis, and nonalcoholic steatohepatitis. Additionally, the company is developing MBX-2982, an orally-active G protein-coupled receptor agonist targeting gut/liver diseases, and CB-001, a preclinical-stage product candidate for treating gut/liver disease using omega-3 fatty acids. CymaBay has partnerships with Janssen Pharmaceuticals and DiaTex for developing therapies for metabolic diseases and gout, respectively.
Argenx is a global immunology company based in the Netherlands, dedicated to enhancing the lives of individuals affected by severe autoimmune diseases and cancer. The company specializes in antibody engineering technology to develop treatments for rare autoimmune conditions. Its lead product, Vyvgart (efgartigimod), received initial approval in the United States in December 2021 for the treatment of generalized myasthenia gravis, followed by subsequent approvals in Europe and Japan in 2022. Through its innovative approaches, Argenx aims to address significant unmet medical needs in the field of immunology.
Pronota NV is a Belgian company focused on developing and commercializing innovative diagnostics aimed at the early detection of life-threatening conditions and addressing unmet medical needs. Established in 2004 and based in Zwijnaarde, the company specializes in non-invasive, validated protein biomarker diagnostics. Its portfolio includes tests for conditions such as heart failure, pre-eclampsia, and sepsis, among others. Pronota is dedicated to enhancing patient care through its proprietary diagnostic solutions. The company benefits from a strong network of investors and key opinion leaders in the medical field, reflecting its commitment to advancing diagnosis and personalized healthcare. Pronota was previously known as Peakadilly NV until its name change in November 2006.
Aristo Music Technology
Venture Round in 2008
Aristo Music NV develops selection and distribution techniques and technologies for digital music and provides music related services. The company also develops various Internet applications, which include a Web radio that consists of a musical database. It serves catering, retail, business, leisure, and government markets. The company is based in Heverlee, Belgium.
Okapi Sciences
Series A in 2008
Okapi Sciences NV is a Belgium-based company focused on developing antiviral therapeutics specifically for pets and livestock. It has a proprietary platform that supports the creation of innovative treatments targeting various viral diseases. The company is advancing its pipeline of clinical and development stage candidates, including drugs intended for feline herpes and feline immunodeficiency virus. Through its research and development efforts, Okapi aims to provide veterinarians with the latest antiviral treatments, enhancing the standards of care for animal health. Targeting both companion animals and livestock, Okapi Sciences is positioned to make significant contributions to veterinary medicine with its novel technologies and strong academic partnerships.
Istrobanka
Acquisition in 2008
Istrobanka is a provider of retail and wholesale banking products and services for corporate and individual customers in Slovakia. The company offers deposit products, savings and investment accounts, loans, corporate finance, insurance products, payment cards, mutual funds, and mortgage loans.
Richelieu Finance
Acquisition in 2008
Richelieu Finance is an investment management company.
Senzal
Acquisition in 2007
Senzal is a privately held company that specializes in providing brokerage services. It operates in the financial sector, focusing on facilitating transactions and offering expertise in security brokerage. Through its services, Senzal aims to support clients in navigating the complexities of the financial markets, ensuring efficient and effective trading solutions. The company is dedicated to delivering personalized service and maintaining a strong commitment to client satisfaction.
Paperspace
Series F in 2007
Paperspace is a cloud computing company that specializes in machine learning (ML) development. It offers a high-performance cloud platform for building, training, and deploying ML models, catering to individuals, startups, and enterprises. The platform provides a cloud-based personal computer accessible via any web browser, making cloud computing more accessible through simplicity, community-driven resources, and straightforward pricing. This enables users to iterate faster and collaborate on real-time prediction engines.
Hipobroker
Acquisition in 2007
Hipobroker is a financial services provider operating in Serbia and Montenegro, specializing in brokerage services. The company facilitates the buying and selling of shares in private market companies, catering to investors seeking to manage and diversify their security portfolios. By offering relevant market information and insights, Hipobroker supports its clients in making informed investment decisions.
Swiss Capital S.A.
Acquisition in 2007
Swiss Capital S.A. is an investment brokerage services in Romania. The company serves institutional clients and high net worth individuals.
CymaBay Therapeutics
Series D in 2007
CymaBay Therapeutics, Inc., established in 1988 and headquartered in Newark, California, is a clinical-stage biopharmaceutical company dedicated to developing therapies for liver diseases and other chronic conditions with significant unmet medical needs. Its primary focus is on seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta, currently in Phase II trials for treating primary biliary cholangitis, sclerosing cholangitis, and nonalcoholic steatohepatitis. Additionally, the company is developing MBX-2982, an orally-active G protein-coupled receptor agonist targeting gut/liver diseases, and CB-001, a preclinical-stage product candidate for treating gut/liver disease using omega-3 fatty acids. CymaBay has partnerships with Janssen Pharmaceuticals and DiaTex for developing therapies for metabolic diseases and gout, respectively.
Romstal Leasing IFN
Acquisition in 2007
Romstal Leasing is the largest independent leasing company in Romania, specializing in a wide range of leasing services. Established as a prominent player in the market, the company primarily focuses on car leasing, which constitutes a significant portion of its financing activities. In addition to personal and commercial vehicle leasing, Romstal Leasing also offers leasing solutions for delivery vans, lorries, machinery, equipment, and real estate. By catering to diverse customer needs across various sectors, Romstal Leasing has established itself as a key provider in the Romanian leasing industry.
DZI Insurance
Acquisition in 2007
DZI is an insurance company based in Bulgaria that offers a diverse array of insurance products, including life, health, accident, travel, and property insurance. In addition to its core insurance services, DZI also engages in bankassurance, integrating banking and insurance services to provide clients with comprehensive financial solutions. The company's extensive offerings cater to various customer needs, making it a significant player in the Bulgarian insurance market.
KBC Equitas
Acquisition in 2007
KBC Equitas is a privately held company that operates an online stock exchange platform and offers online brokerage services. Its primary business involves facilitating the trading of various financial instruments such as investment funds, shares, equities, certificates, exchange-traded funds, treasury bills, and futures through its advanced online trading system. The company aims to empower clients in preserving and enriching their wealth through these services.
Movetis NV is a pharmaceutical company dedicated to the discovery, development, and commercialization of drugs targeting gastrointestinal (GI) disorders. Founded in 2006 and headquartered in Turnhout, Belgium, Movetis focuses on conditions such as severe chronic constipation, ascites, pediatric reflux, and complex GI motility disorders like refractory gastro-oesophageal reflux disease. The company's lead product, Resolor, is specifically developed for the symptomatic treatment of chronic constipation in women, with ongoing research to extend its use to males, children, and conditions like opioid-induced constipation and postoperative ileus. Movetis is also advancing other candidates in its pipeline, including M0002, currently in Phase II trials for ascites, and M0003, which is entering Phase II development for treating heartburn and pediatric reflux in patients resistant to proton pump inhibitors. Additionally, the company has prioritized compounds from its preclinical portfolio and maintains partnerships with several academic institutions in Belgium and the Netherlands to enhance its research capabilities.
Banco Urquijo
Acquisition in 2006
Banco Urquijo specializes in advising and managing legal entities, such as insurance companies, mutual companies, provident societies, cooperatives, and trusts that administer third party assets.
Ablynx is a biopharmaceutical company focused on discovering and developing Nanobodies®, a unique class of therapeutic proteins derived from single-domain antibody fragments. These Nanobodies are designed to treat serious human diseases, including inflammation, hematology, oncology, and pulmonary conditions. The company currently has around 25 projects in its pipeline, with five Nanobodies in clinical development. Ablynx's products aim to combine the advantages of conventional antibodies and small chemical molecules, offering patients innovative therapeutic options that can significantly impact society.
Pronota NV is a Belgian company focused on developing and commercializing innovative diagnostics aimed at the early detection of life-threatening conditions and addressing unmet medical needs. Established in 2004 and based in Zwijnaarde, the company specializes in non-invasive, validated protein biomarker diagnostics. Its portfolio includes tests for conditions such as heart failure, pre-eclampsia, and sepsis, among others. Pronota is dedicated to enhancing patient care through its proprietary diagnostic solutions. The company benefits from a strong network of investors and key opinion leaders in the medical field, reflecting its commitment to advancing diagnosis and personalized healthcare. Pronota was previously known as Peakadilly NV until its name change in November 2006.
K&H Bank
Acquisition in 2006
K&H Bank is a banking institution based in Budapest, Hungary, established in 1987. It operates as a wholly owned subsidiary of KBC Bank and serves both retail and corporate clients. The bank offers a comprehensive range of financial services, including lending, digital banking, insurance, wealth management, advisory, and transaction services. Additionally, K&H Bank provides specialized financial solutions such as corporate finance, agricultural loans, leasing, and local government funding, catering to diverse customer needs in the financial sector.
HSBC Dewaay S.A.
Acquisition in 2005
HSBC Dewaay SA is a privately held company offers private banking and trustee services. It services include cash management, discretionary portfolio management, and patrimonial advisory services.
Effectenbank Stroeve N.V.
Acquisition in 2005
Effectenbank Stroeve N.V. is a privately held company offers capital management, stockbroking, and investment advisory services.
Aurel Leven
Acquisition in 2005
Aurel Leven Gestion, an independent asset management company, old, which manages funds on behalf of private clients and institutional investors. Aurel Leven Gestion, of February 2005, Aurel Leven Gestion was acquired by KBL France Gestion.
Aballea Finance
Acquisition in 2005
Aballea Finance SA is a privately held company specializing in wealth management and real estate management. The firm offers a range of financial advisory services, including real estate consulting, tax assistance, investment management, and financial reporting. Aballea Finance focuses on delivering tailored solutions to meet the diverse needs of its clients, ensuring effective management of their financial assets and real estate investments.
Almanij NV
Acquisition in 2005
Almanij NV engages in banking, insurance, and investment activities; and the provision of specialized financial services.
CymaBay Therapeutics
Series B in 2004
CymaBay Therapeutics, Inc., established in 1988 and headquartered in Newark, California, is a clinical-stage biopharmaceutical company dedicated to developing therapies for liver diseases and other chronic conditions with significant unmet medical needs. Its primary focus is on seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta, currently in Phase II trials for treating primary biliary cholangitis, sclerosing cholangitis, and nonalcoholic steatohepatitis. Additionally, the company is developing MBX-2982, an orally-active G protein-coupled receptor agonist targeting gut/liver diseases, and CB-001, a preclinical-stage product candidate for treating gut/liver disease using omega-3 fatty acids. CymaBay has partnerships with Janssen Pharmaceuticals and DiaTex for developing therapies for metabolic diseases and gout, respectively.
Banca KBL Fumagalli Soldan S.p.A.
Acquisition in 2004
Banca KBL Fumagalli Soldan S.p.A. offers corporate, retail and private and investment banking services. It provides financial services worldwide.
WARTA S.A.
Acquisition in 2003
WARTA S.A., established in 1920, is one of the largest and oldest insurance companies in Poland, recognized for setting standards in the country's insurance market. Headquartered in Warsaw, the company operates as a reinsurance broker and provides a diverse range of insurance products. Its offerings include motor, property, personal, financial, and third-party liability insurance, catering to various customer needs and contributing to the overall stability of the Polish insurance sector.